Symbollon Pharmaceuticals Forms Joint Venture with Internet Marketing Consortium to Promote Iogen(TM)

Published: Jun 21, 2010

MEDFIELD, Mass., June 21, 2010 (GLOBE NEWSWIRE) -- Symbollon Pharmaceuticals, Inc. (OTCBB:SYMBA) ( has announced today it has signed a non-exclusive joint venture agreement with Internet Marketing Consortium (IMC) to promote Iogen™. The purpose of the joint venture is to utilize the proprietary internet and multi-media marketing strategies and networks to promote Iogen™ through website sales on IMC is part of Beryl Wolk's family-owned businesses comprising 27 autonomous companies, employing 1,250 employees, with major facilities in four states and 66 offices worldwide. The parties will share 50/50% in the profits of the joint venture. Iogen™ is the first dietary supplement formulated to promote breast health for women suffering from breast pain and breast tenderness, fibrocystic breast disease, benign breast lumps and cysts.

Back to news